Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions.
- Published In:
- bioRxiv : the preprint server for biology (2024)
- Authors:
- Bjørn-Yoshimoto, Walden E, Ramiro, Iris Bea L, Koch, Thomas Lund, Engholm, Ebbe, Yeung, Ho Yan, Sørensen, Kasper K, Goddard, Carolyn M, Jensen, Kathrine L, Smith, Nicholas A, Martin, Laurent F, Smith, Brian J, Madsen, Kenneth L, Jensen, Knud J, Patwardhan, Amol, Safavi-Hemami, Helena
- Database ID:
- RPEP-07865
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07865APA
Bjørn-Yoshimoto, Walden E; Ramiro, Iris Bea L; Koch, Thomas Lund; Engholm, Ebbe; Yeung, Ho Yan; Sørensen, Kasper K; Goddard, Carolyn M; Jensen, Kathrine L; Smith, Nicholas A; Martin, Laurent F; Smith, Brian J; Madsen, Kenneth L; Jensen, Knud J; Patwardhan, Amol; Safavi-Hemami, Helena. (2024). Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2024.04.29.591104
MLA
Bjørn-Yoshimoto, Walden E, et al. "Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions.." bioRxiv : the preprint server for biology, 2024. https://doi.org/10.1101/2024.04.29.591104
RethinkPeptides
RethinkPeptides Research Database. "Venom-inspired somatostatin receptor 4 (SSTR4) agonists as n..." RPEP-07865. Retrieved from https://rethinkpeptides.com/research/bjorn-yoshimoto-2024-venominspired-somatostatin-receptor-4
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.